サマリー

ノルカンタリジンは、漢方薬の主な抗がん成分であるカンタリジンを加水分解してジメチルにした合成抗がん剤、すなわちカンタリジンの誘導体である。

市場分析と洞察。世界のNorcantharidin市場
世界のNorcantharidin市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のNorcantharidin市場で利用可能な主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には収益面での世界のNorcantharidin市場全体のサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のNorcantharidin市場で永続的な成功を収めるために利用できる効果的なツールであることを証明しています。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のNorcantharidin市場を詳細に調査するために、独自の業界最高水準の調査・分析アプローチを採用しました。

世界のNorcantharidinの範囲と市場規模
ノルカンタリジン市場は、企業別、地域（国）別、タイプ別、用途別に分類されています。世界のNorcantharidin市場に参加するプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
植物性医薬品
ホルモン系
ターゲット 低分子医薬品
薬剤耐性の代謝

アプリケーション別セグメント
肝臓がん
食道癌
胃癌
心臓癌
低血糖症
肝炎・肝硬変
B型肝炎ウイルス

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ファルマシア
日本化薬
ファイザー
MATRIX
上海兆輝製薬
同方製薬グループ
海南通勇通蒙製薬（Hainan Tongyong Tongmeng Pharmaceutical
Qilu製薬
江蘇省 衡瑞製薬
漢恵製薬
華北製薬
山東シャンダ カンヌオ製薬
北京万輝双和製薬
鶯歌舞志通製薬
山東Renhetang製薬
山東信義製薬
シノファーム
広東建新製薬
西安海信製薬

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Norcantharidin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Plant Medicine
1.2.3 Hormone
1.2.4 Target Small Molecule Drugs
1.2.5 Metabolism Of Drug Resistance
1.3 Market by Application
1.3.1 Global Norcantharidin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Liver Cancer
1.3.3 Esophageal Cancer
1.3.4 Stomach Cancer
1.3.5 Cardia Cancer
1.3.6 Hypoleucosis
1.3.7 Hepatitis & Cirrhosis Of The Liver
1.3.8 Hepatitis B Virus
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Norcantharidin Market Perspective (2016-2027)
2.2 Norcantharidin Growth Trends by Regions
2.2.1 Norcantharidin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Norcantharidin Historic Market Share by Regions (2016-2021)
2.2.3 Norcantharidin Forecasted Market Size by Regions (2022-2027)
2.3 Norcantharidin Industry Dynamic
2.3.1 Norcantharidin Market Trends
2.3.2 Norcantharidin Market Drivers
2.3.3 Norcantharidin Market Challenges
2.3.4 Norcantharidin Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Norcantharidin Players by Revenue
3.1.1 Global Top Norcantharidin Players by Revenue (2016-2021)
3.1.2 Global Norcantharidin Revenue Market Share by Players (2016-2021)
3.2 Global Norcantharidin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Norcantharidin Revenue
3.4 Global Norcantharidin Market Concentration Ratio
3.4.1 Global Norcantharidin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Norcantharidin Revenue in 2020
3.5 Norcantharidin Key Players Head office and Area Served
3.6 Key Players Norcantharidin Product Solution and Service
3.7 Date of Enter into Norcantharidin Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Norcantharidin Breakdown Data by Type
4.1 Global Norcantharidin Historic Market Size by Type (2016-2021)
4.2 Global Norcantharidin Forecasted Market Size by Type (2022-2027)

5 Norcantharidin Breakdown Data by Application
5.1 Global Norcantharidin Historic Market Size by Application (2016-2021)
5.2 Global Norcantharidin Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Norcantharidin Market Size (2016-2027)
6.2 North America Norcantharidin Market Size by Type
6.2.1 North America Norcantharidin Market Size by Type (2016-2021)
6.2.2 North America Norcantharidin Market Size by Type (2022-2027)
6.2.3 North America Norcantharidin Market Size by Type (2016-2027)
6.3 North America Norcantharidin Market Size by Application
6.3.1 North America Norcantharidin Market Size by Application (2016-2021)
6.3.2 North America Norcantharidin Market Size by Application (2022-2027)
6.3.3 North America Norcantharidin Market Size by Application (2016-2027)
6.4 North America Norcantharidin Market Size by Country
6.4.1 North America Norcantharidin Market Size by Country (2016-2021)
6.4.2 North America Norcantharidin Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Norcantharidin Market Size (2016-2027)
7.2 Europe Norcantharidin Market Size by Type
7.2.1 Europe Norcantharidin Market Size by Type (2016-2021)
7.2.2 Europe Norcantharidin Market Size by Type (2022-2027)
7.2.3 Europe Norcantharidin Market Size by Type (2016-2027)
7.3 Europe Norcantharidin Market Size by Application
7.3.1 Europe Norcantharidin Market Size by Application (2016-2021)
7.3.2 Europe Norcantharidin Market Size by Application (2022-2027)
7.3.3 Europe Norcantharidin Market Size by Application (2016-2027)
7.4 Europe Norcantharidin Market Size by Country
7.4.1 Europe Norcantharidin Market Size by Country (2016-2021)
7.4.2 Europe Norcantharidin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Norcantharidin Market Size (2016-2027)
8.2 Asia-Pacific Norcantharidin Market Size by Type
8.2.1 Asia-Pacific Norcantharidin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Norcantharidin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Norcantharidin Market Size by Type (2016-2027)
8.3 Asia-Pacific Norcantharidin Market Size by Application
8.3.1 Asia-Pacific Norcantharidin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Norcantharidin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Norcantharidin Market Size by Application (2016-2027)
8.4 Asia-Pacific Norcantharidin Market Size by Region
8.4.1 Asia-Pacific Norcantharidin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Norcantharidin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Norcantharidin Market Size (2016-2027)
9.2 Latin America Norcantharidin Market Size by Type
9.2.1 Latin America Norcantharidin Market Size by Type (2016-2021)
9.2.2 Latin America Norcantharidin Market Size by Type (2022-2027)
9.2.3 Latin America Norcantharidin Market Size by Type (2016-2027)
9.3 Latin America Norcantharidin Market Size by Application
9.3.1 Latin America Norcantharidin Market Size by Application (2016-2021)
9.3.2 Latin America Norcantharidin Market Size by Application (2022-2027)
9.3.3 Latin America Norcantharidin Market Size by Application (2016-2027)
9.4 Latin America Norcantharidin Market Size by Country
9.4.1 Latin America Norcantharidin Market Size by Country (2016-2021)
9.4.2 Latin America Norcantharidin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Norcantharidin Market Size (2016-2027)
10.2 Middle East & Africa Norcantharidin Market Size by Type
10.2.1 Middle East & Africa Norcantharidin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Norcantharidin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Norcantharidin Market Size by Type (2016-2027)
10.3 Middle East & Africa Norcantharidin Market Size by Application
10.3.1 Middle East & Africa Norcantharidin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Norcantharidin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Norcantharidin Market Size by Application (2016-2027)
10.4 Middle East & Africa Norcantharidin Market Size by Country
10.4.1 Middle East & Africa Norcantharidin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Norcantharidin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pharmacia
11.1.1 Pharmacia Company Details
11.1.2 Pharmacia Business Overview
11.1.3 Pharmacia Norcantharidin Introduction
11.1.4 Pharmacia Revenue in Norcantharidin Business (2016-2021)
11.1.5 Pharmacia Recent Development
11.2 Nippon Kayaku
11.2.1 Nippon Kayaku Company Details
11.2.2 Nippon Kayaku Business Overview
11.2.3 Nippon Kayaku Norcantharidin Introduction
11.2.4 Nippon Kayaku Revenue in Norcantharidin Business (2016-2021)
11.2.5 Nippon Kayaku Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Norcantharidin Introduction
11.3.4 Pfizer Revenue in Norcantharidin Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 MATRIX
11.4.1 MATRIX Company Details
11.4.2 MATRIX Business Overview
11.4.3 MATRIX Norcantharidin Introduction
11.4.4 MATRIX Revenue in Norcantharidin Business (2016-2021)
11.4.5 MATRIX Recent Development
11.5 Shanghai Zhaohui Pharmaceutical
11.5.1 Shanghai Zhaohui Pharmaceutical Company Details
11.5.2 Shanghai Zhaohui Pharmaceutical Business Overview
11.5.3 Shanghai Zhaohui Pharmaceutical Norcantharidin Introduction
11.5.4 Shanghai Zhaohui Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.5.5 Shanghai Zhaohui Pharmaceutical Recent Development
11.6 Tongfang Pharmaceutical Group
11.6.1 Tongfang Pharmaceutical Group Company Details
11.6.2 Tongfang Pharmaceutical Group Business Overview
11.6.3 Tongfang Pharmaceutical Group Norcantharidin Introduction
11.6.4 Tongfang Pharmaceutical Group Revenue in Norcantharidin Business (2016-2021)
11.6.5 Tongfang Pharmaceutical Group Recent Development
11.7 Hainan Tongyong Tongmeng Pharmaceutical
11.7.1 Hainan Tongyong Tongmeng Pharmaceutical Company Details
11.7.2 Hainan Tongyong Tongmeng Pharmaceutical Business Overview
11.7.3 Hainan Tongyong Tongmeng Pharmaceutical Norcantharidin Introduction
11.7.4 Hainan Tongyong Tongmeng Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.7.5 Hainan Tongyong Tongmeng Pharmaceutical Recent Development
11.8 Qilu Pharmaceutical
11.8.1 Qilu Pharmaceutical Company Details
11.8.2 Qilu Pharmaceutical Business Overview
11.8.3 Qilu Pharmaceutical Norcantharidin Introduction
11.8.4 Qilu Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.8.5 Qilu Pharmaceutical Recent Development
11.9 Jiangsu Hengrui Pharmaceutical
11.9.1 Jiangsu Hengrui Pharmaceutical Company Details
11.9.2 Jiangsu Hengrui Pharmaceutical Business Overview
11.9.3 Jiangsu Hengrui Pharmaceutical Norcantharidin Introduction
11.9.4 Jiangsu Hengrui Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.9.5 Jiangsu Hengrui Pharmaceutical Recent Development
11.10 Hanhui Pharmaceutical
11.10.1 Hanhui Pharmaceutical Company Details
11.10.2 Hanhui Pharmaceutical Business Overview
11.10.3 Hanhui Pharmaceutical Norcantharidin Introduction
11.10.4 Hanhui Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.10.5 Hanhui Pharmaceutical Recent Development
11.11 Huabei Pharmaceutical
11.11.1 Huabei Pharmaceutical Company Details
11.11.2 Huabei Pharmaceutical Business Overview
11.11.3 Huabei Pharmaceutical Norcantharidin Introduction
11.11.4 Huabei Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.11.5 Huabei Pharmaceutical Recent Development
11.12 Shandong Shanda Kangnuo Pharmaceutical
11.12.1 Shandong Shanda Kangnuo Pharmaceutical Company Details
11.12.2 Shandong Shanda Kangnuo Pharmaceutical Business Overview
11.12.3 Shandong Shanda Kangnuo Pharmaceutical Norcantharidin Introduction
11.12.4 Shandong Shanda Kangnuo Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.12.5 Shandong Shanda Kangnuo Pharmaceutical Recent Development
11.13 Beijing Wanhui Shuanghe Pharmaceutical
11.13.1 Beijing Wanhui Shuanghe Pharmaceutical Company Details
11.13.2 Beijing Wanhui Shuanghe Pharmaceutical Business Overview
11.13.3 Beijing Wanhui Shuanghe Pharmaceutical Norcantharidin Introduction
11.13.4 Beijing Wanhui Shuanghe Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.13.5 Beijing Wanhui Shuanghe Pharmaceutical Recent Development
11.14 Yingzi Maishitong Pharmaceutical
11.14.1 Yingzi Maishitong Pharmaceutical Company Details
11.14.2 Yingzi Maishitong Pharmaceutical Business Overview
11.14.3 Yingzi Maishitong Pharmaceutical Norcantharidin Introduction
11.14.4 Yingzi Maishitong Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.14.5 Yingzi Maishitong Pharmaceutical Recent Development
11.15 Shandong Renhetang Pharmaceutical
11.15.1 Shandong Renhetang Pharmaceutical Company Details
11.15.2 Shandong Renhetang Pharmaceutical Business Overview
11.15.3 Shandong Renhetang Pharmaceutical Norcantharidin Introduction
11.15.4 Shandong Renhetang Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.15.5 Shandong Renhetang Pharmaceutical Recent Development
11.16 Shandong Xinyi Pharmaceutical
11.16.1 Shandong Xinyi Pharmaceutical Company Details
11.16.2 Shandong Xinyi Pharmaceutical Business Overview
11.16.3 Shandong Xinyi Pharmaceutical Norcantharidin Introduction
11.16.4 Shandong Xinyi Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.16.5 Shandong Xinyi Pharmaceutical Recent Development
11.17 Sinopharm
11.17.1 Sinopharm Company Details
11.17.2 Sinopharm Business Overview
11.17.3 Sinopharm Norcantharidin Introduction
11.17.4 Sinopharm Revenue in Norcantharidin Business (2016-2021)
11.17.5 Sinopharm Recent Development
11.18 Guangdong Jianxin Pharmaceutical
11.18.1 Guangdong Jianxin Pharmaceutical Company Details
11.18.2 Guangdong Jianxin Pharmaceutical Business Overview
11.18.3 Guangdong Jianxin Pharmaceutical Norcantharidin Introduction
11.18.4 Guangdong Jianxin Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.18.5 Guangdong Jianxin Pharmaceutical Recent Development
11.18 Xi 'an Haixin Pharmaceutical
.1 Xi 'an Haixin Pharmaceutical Company Details
.2 Xi 'an Haixin Pharmaceutical Business Overview
.3 Xi 'an Haixin Pharmaceutical Norcantharidin Introduction
.4 Xi 'an Haixin Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
.5 Xi 'an Haixin Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details